Starpharma Valor da empresa
Qual é o Valor da empresa de Starpharma?
O Valor da empresa de Starpharma Holdings Limited é $114.27M
Qual é a definição de Valor da empresa?
O valor da empresa é uma medida do valor total de mercado de uma empresa. É calculado como capitalização de mercado com dívida, participação minoritária e ações preferenciais menos o total de caixa e equivalentes de caixa.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor da empresa de empresas na Setor Health Care em ASX em comparação com Starpharma
O que Starpharma faz?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Empresas com valor da empresa semelhantes a Starpharma
- Pure Gold Mining tem Valor da empresa de $113.91M
- Suoxinda tem Valor da empresa de $114.05M
- Amaroq Minerals Ltd tem Valor da empresa de $114.10M
- Dixie tem Valor da empresa de $114.16M
- smartphoto group NV tem Valor da empresa de $114.18M
- Ramco Systems tem Valor da empresa de $114.25M
- Starpharma tem Valor da empresa de $114.27M
- Alpha Real Trust tem Valor da empresa de $114.32M
- Sylogist tem Valor da empresa de $114.35M
- ScS Plc tem Valor da empresa de $114.38M
- Paragon ID SA tem Valor da empresa de $114.38M
- Probe Metals tem Valor da empresa de $114.42M
- Zoetic International Plc tem Valor da empresa de $114.43M